| Hamid Hassanzadeh, MD | |
|
6420 Rockledge Dr Ste 2200, Bethesda, MD 20817-7842 | |
| (240) 762-5100 | |
| (410) 367-2237 |
| Full Name | Hamid Hassanzadeh |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 6420 Rockledge Dr Ste 2200, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710140595 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Home Health Services | Silver spring, MD | Home health agency |
| Suburban Hospital | Bethesda, MD | Hospital |
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 4981745098 | 571 |
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood.
A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research led by scientists at Dana-Farber Cancer Institute showed the drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
Leti researchers have demonstrated that memristive devices are excellent candidates to emulate synaptic plasticity, the capability of synapses to enhance or diminish their connectivity between neurons, which is widely believed to be the cellular basis for learning and memory.
Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013913789 PECOS PAC ID: 4981745098 Enrollment ID: O20130925000065 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood.
A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research led by scientists at Dana-Farber Cancer Institute showed the drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
Leti researchers have demonstrated that memristive devices are excellent candidates to emulate synaptic plasticity, the capability of synapses to enhance or diminish their connectivity between neurons, which is widely believed to be the cellular basis for learning and memory.
Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hamid Hassanzadeh, MD 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: (410) 933-6423 | Hamid Hassanzadeh, MD 6420 Rockledge Dr Ste 2200, Bethesda, MD 20817-7842 Ph: (240) 762-5100 |
News Archive
Attention Deficit Hyperactivity Disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood.
A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research led by scientists at Dana-Farber Cancer Institute showed the drug and a potentiating agent lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
Leti researchers have demonstrated that memristive devices are excellent candidates to emulate synaptic plasticity, the capability of synapses to enhance or diminish their connectivity between neurons, which is widely believed to be the cellular basis for learning and memory.
Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 5 days ago
John Joseph Christoforetti Ii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6710a Rockledge Dr Ste 130, Bethesda, MD 20817 Phone: 301-515-0900 Fax: 240-912-2381 | |
Dr. Scott Lyngklip Nasson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-9183 Fax: 301-295-4141 | |
John Robert Renehan, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: Wrnmmc, 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-295-4000 | |
Min Lu, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10215 Fernwood Rd Ste 506, Bethesda, MD 20817 Phone: 301-530-1010 | |
Dr. Sridhar Durbhakula, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10215 Fernwood Rd, Suite 506, Bethesda, MD 20817 Phone: 301-530-1010 Fax: 301-897-8597 | |
Dr. Andrew William Mack, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4290 | |
Alfred Pisano, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bldg 1, Floor 19, Room 19107, Bethesda, MD 20889 Phone: 301-319-8373 Fax: 301-295-9186 |